651 related items for PubMed ID: 21301358
1. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[Abstract] [Full Text] [Related]
2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[Abstract] [Full Text] [Related]
3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[Abstract] [Full Text] [Related]
4. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
Abbas Z, Yakoob J, Jafri W, Ahmad Z, Azam Z, Usman MW, Shamim S, Islam M.
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560
[Abstract] [Full Text] [Related]
5. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S, Mora D, Gschwender M, Popp K.
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[Abstract] [Full Text] [Related]
6. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ.
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[Abstract] [Full Text] [Related]
7. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C.
Aliment Pharmacol Ther; 2007 Aug 01; 26(3):475-86. PubMed ID: 17635382
[Abstract] [Full Text] [Related]
8. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC.
Scand J Gastroenterol; 2012 Oct 01; 47(10):1159-64. PubMed ID: 22783919
[Abstract] [Full Text] [Related]
9. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
Am J Gastroenterol; 2006 Jul 01; 101(7):1574-80. PubMed ID: 16863563
[Abstract] [Full Text] [Related]
10. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
[Abstract] [Full Text] [Related]
11. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC, Croffut RM, Stranahan MC.
Clin Ther; 2005 Jun 15; 27(6):755-61. PubMed ID: 16117982
[Abstract] [Full Text] [Related]
12. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J.
Arq Gastroenterol; 2013 Jun 15; 50(4):304-9. PubMed ID: 24474234
[Abstract] [Full Text] [Related]
13. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M.
J Pediatr Gastroenterol Nutr; 2010 Jul 15; 51(1):24-30. PubMed ID: 20453678
[Abstract] [Full Text] [Related]
14. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM.
Aliment Pharmacol Ther; 2009 Jan 15; 29(1):97-103. PubMed ID: 18785988
[Abstract] [Full Text] [Related]
15. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
Simrén M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, Strid H.
Aliment Pharmacol Ther; 2010 Jan 15; 31(2):218-27. PubMed ID: 19863495
[Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.
Am J Gastroenterol; 2010 Jan 15; 105(1):170-7. PubMed ID: 19809408
[Abstract] [Full Text] [Related]
17. Role of Saccharomyces boulardii in diarrhea predominant irritable bowel syndrome.
Kabir MA, Ishaque SM, Ali MS, Mahmuduzzaman M, Hasan M.
Mymensingh Med J; 2011 Jul 15; 20(3):397-401. PubMed ID: 21804501
[Abstract] [Full Text] [Related]
18. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
[Abstract] [Full Text] [Related]
19. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.
Aliment Pharmacol Ther; 2005 Sep 01; 22(5):387-94. PubMed ID: 16128676
[Abstract] [Full Text] [Related]
20. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
Gastroenterology; 2013 Aug 01; 145(2):329-38.e1. PubMed ID: 23583433
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
